Scrip Asks…What Does 2024 Hold For Biopharma? Part 1: Business Strategy And Leadership
Article
Citeline
About this article
Challenges will continue to buffet the biopharma industry in 2024 as leadership teams face multiple global crises and limited funding. Biopharma companies need to work harder — and smarter — than ever to thrive amid these headwinds.
To that end, more than 20 industry leaders share with Scrip their perspectives on how companies should be shaping strategy and leadership in 2024.
Key topics covered in this article include:
- Patient focus
- Partnership
- Investment in innovation
